Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Gastroenterology|July 13, 2000
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel diseaseJ A Tibble, G Sigthorsson, S Bridger, et al.
Gut|March 1, 1992
Intestinal permeability in patients with Crohn's disease and their first degree relativesK Teahon, P Smethurst, A J Levi, et al.
Gut|March 1, 1991
Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in manI Bjarnason, B Fehilly, P Smethurst, et al.
Gut|March 1, 1996
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteriaA Macpherson, U Y Khoo, I Forgacs, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2015
Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?P Pavlidis, N Powell, R P Vincent, et al.
Arthritis and Rheumatism|December 1, 1996
Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylationT Mahmud, S S Rafi, D L Scott, et al.
Scandinavian Journal of Gastroenterology|July 1, 1991
The effect of polyacrylic acid polymers on small-intestinal function and permeability changes caused by indomethacinI Bjarnason, P Smethurst, A J Levi, et al.
Gut|November 1, 1985
Intestinal permeability in patients with coeliac disease and dermatitis herpetiformisI Bjarnason, M N Marsh, A Price, et al.
BMC Gastroenterology|April 19, 2002
2, 4-diamino-6- hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunumS Somasundaram, R Simpson, S Rafi, et al.
Gut|September 1, 1996
Evaluation of differential disaccharide excretion in urine for non-invasive investigation of altered intestinal disaccharidase activity caused by alpha-glucosidase inhibition, primary hypolactasia, and coeliac diseaseI Bjarnason, R Batt, S Catt, et al.
Pageof 13